CASR and breast neoplasm: Finally, we examined CaSR protein expression using the semi-automated immunofluorescence AQUA platform in a tissue microarray consisting of 652 breast tumors with a median clinical follow up of 8.9 years (YTMA49) (Camp et al., 2002; VanHouten et al., 2010).